GLUMON has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement No. 101058111.
GLUMON aims to leverage a new class of a biomedical optoacoustic sensor, to offer the next generation in-blood non-invasive biochemical sensing in-vivo, thus addressing the limitations of existing biomedical sensors.
The content of this account and any related posts reflect only the views of its authors. The European Commission is not responsible for any use that may be made of the information it contains.
Company Details
- Address
- Munich , De
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://glumon.munichimaging.eu/
- HQ
- Munich
Glumon Questions
Glumon's website is https://glumon.munichimaging.eu/
Glumon's LinkedIn profile is https://de.linkedin.com/company/glumon2022
Glumon's industry is
Research Services
Glumon's top competitors are
Munichimaging,
Precipoint,
Chromsystems,
Basecamp Research,
Bloom Medical Imaging,
Wecf International,
Sthesis Gmbh,
Helmholtz Munich.
Glumon's categories are Research Services
